$FACT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT BIOTHERAPEUTICS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ABBOTT BIOTHERAPEUTICS CORP. Get notifications about new insider transactions in ABBOTT BIOTHERAPEUTICS CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 27 2010 | FACT | ABBOTT BIOTHERAPEU ... | ABBOTT BIOTHERAPEUTICS CORP | 10% Owner | Sell | J | 0.00 | 2,243,649 | 0 | 0 | 2.2 M to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | EMSTER KURT VON | Director | Option Exercise | D | 9.56 | 3,334 | 31,873 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | EMSTER KURT VON | Director | Option Exercise | D | 6.50 | 16,667 | 108,336 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | EMSTER KURT VON | Director | Sell | D | 27.00 | 1,667 | 45,009 | 0 | 1.7 K to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP Gen Counsel & Se ... | Option Exercise | D | 9.95 | 29,800 | 296,510 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP Gen Counsel & Se ... | Option Exercise | D | 9.55 | 6,422 | 61,330 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP Gen Counsel & Se ... | Option Exercise | D | 6.17 | 32,000 | 197,440 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP Gen Counsel & Se ... | Sell | D | 27.00 | 16,277 | 439,479 | 0 | 16.3 K to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Parkinson David Ross | Director | Option Exercise | D | 9.56 | 5,000 | 47,800 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Parkinson David Ross | Director | Option Exercise | D | 6.17 | 16,667 | 102,835 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Parkinson David Ross | Director | Sell | D | 27.00 | 2,500 | 67,500 | 0 | 2.5 K to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | LYONS GARY A | Director | Option Exercise | D | 9.56 | 5,000 | 47,800 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | LYONS GARY A | Director | Option Exercise | D | 6.17 | 16,667 | 102,835 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | LYONS GARY A | Director | Sell | D | 27.00 | 2,500 | 67,500 | 0 | 2.5 K to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Rolfe Mark | Sr. Vice Pres. and ... | Option Exercise | D | 10.86 | 64,000 | 695,040 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Rolfe Mark | Sr. Vice Pres. and ... | Sell | D | 27.00 | 21,333 | 575,991 | 0 | 21.3 K to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Llana Ted | DVP Comm'l & Corp. ... | Option Exercise | D | 9.95 | 26,693 | 265,595 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Llana Ted | DVP Comm'l & Corp. ... | Option Exercise | D | 6.17 | 64,000 | 394,880 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Llana Ted | DVP Comm'l & Corp. ... | Sell | D | 27.00 | 39,893 | 1,077,111 | 0 | 39.9 K to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Huh Hoyoung | Director | Option Exercise | D | 15.38 | 16,667 | 256,338 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Huh Hoyoung | Director | Sell | D | 27.00 | 8,333 | 224,991 | 0 | 8.3 K to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP, Prod Ops. & Qua ... | Option Exercise | D | 9.95 | 16,000 | 159,200 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP, Prod Ops. & Qua ... | Option Exercise | D | 9.55 | 16,856 | 160,975 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP, Prod Ops. & Qua ... | Option Exercise | D | 6.17 | 32,000 | 197,440 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP, Prod Ops. & Qua ... | Sell | D | 27.00 | 13,803 | 372,681 | 0 | 13.8 K to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Hasnain Faheem | President & CEO | Option Exercise | D | 9.95 | 83,000 | 825,850 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Hasnain Faheem | President & CEO | Option Exercise | D | 6.17 | 300,000 | 1,851,000 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Hasnain Faheem | President & CEO | Sell | D | 27.00 | 102,667 | 2,772,009 | 0 | 102.7 K to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Goodwin Bradford S | Director | Option Exercise | D | 9.56 | 6,667 | 63,737 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Goodwin Bradford S | Director | Option Exercise | D | 6.17 | 20,000 | 123,400 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | Goodwin Bradford S | Director | Sell | D | 27.00 | 3,334 | 90,018 | 0 | 3.3 K to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Option Exercise | D | 9.95 | 45,760 | 455,312 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Option Exercise | D | 9.55 | 20,980 | 200,359 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Option Exercise | D | 6.17 | 64,000 | 394,880 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Sell | D | 27.00 | 32,090 | 866,430 | 0 | 32.1 K to 0 (-100.00 %) |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | VP of Finance | Option Exercise | D | 9.95 | 7,000 | 69,650 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | VP of Finance | Option Exercise | D | 9.55 | 6,866 | 65,570 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | VP of Finance | Option Exercise | D | 6.17 | 14,000 | 86,380 | 0 | |
Apr 23 2010 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | VP of Finance | Sell | D | 27.00 | 11,602 | 313,254 | 0 | 11.6 K to 0 (-100.00 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | EMSTER KURT VON | Director | Sell | U | 27.00 | 8,333 | 224,991 | 1,667 | 10 K to 1.7 K (-83.33 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP Gen Counsel & Se ... | Sell | U | 27.00 | 9,875 | 266,625 | 16,227 | 26.1 K to 16.2 K (-37.83 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | LYONS GARY A | Director | Sell | U | 27.00 | 8,333 | 224,991 | 2,500 | 10.8 K to 2.5 K (-76.92 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP, Prod Ops. & Qua ... | Sell | U | 27.00 | 7,516 | 202,932 | 13,803 | 21.3 K to 13.8 K (-35.25 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | Llana Ted | SVP Comm'l & Corp. ... | Sell | U | 27.00 | 2,989 | 80,703 | 39,893 | 42.9 K to 39.9 K (-6.97 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Sell | U | 27.00 | 12,383 | 334,341 | 32,090 | 44.5 K to 32.1 K (-27.84 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | Goodwin Bradford S | Director | Sell | U | 27.00 | 10,000 | 270,000 | 3,334 | 13.3 K to 3.3 K (-75.00 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | Hasnain Faheem | President & CEO | Sell | U | 27.00 | 18,463 | 498,501 | 102,667 | 121.1 K to 102.7 K (-15.24 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | Rolfe Mark | Sr. Vice Pres. and ... | Sell | U | 27.00 | 1,113 | 30,051 | 21,333 | 22.4 K to 21.3 K (-4.96 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | Parkinson David Ross | Director | Sell | U | 27.00 | 8,333 | 224,991 | 2,500 | 10.8 K to 2.5 K (-76.92 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | VP of Finance/Prin ... | Sell | U | 27.00 | 5,281 | 142,587 | 11,602 | 16.9 K to 11.6 K (-31.28 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | ABBOTT LABORATORIES | 10% Owner | Buy | J | 27.00 | 5,980,034 | 161,460,918 | 1,000 | -5,979,034 to 1,000 (-100.02 %) |
Apr 21 2010 | FACT | ABBOTT BIOTHERAPEU ... | ABBOTT LABORATORIES | 10% Owner | Buy | P | 27.00 | 62,652,055 | 1,691,605,485 | 81,909,724 | 19.3 M to 81.9 M (+325.34 %) |
Apr 05 2010 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Payment of Exercise | F | 26.98 | 1,516 | 40,902 | 44,473 | 46 K to 44.5 K (-3.30 %) |
Feb 09 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.69 | 11,000 | 172,563 | 3,940,070 | 3.9 M to 3.9 M (+0.28 %) |
Feb 09 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.69 | 3,000 | 47,063 | 3,929,070 | 3.9 M to 3.9 M (+0.08 %) |
Feb 09 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.69 | 5,000 | 78,438 | 3,926,070 | 3.9 M to 3.9 M (+0.13 %) |
Feb 09 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.37 | 9,000 | 138,290 | 3,921,070 | 3.9 M to 3.9 M (+0.23 %) |
Feb 09 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.37 | 3,000 | 46,100 | 3,912,070 | 3.9 M to 3.9 M (+0.08 %) |
Feb 09 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.37 | 3,200 | 49,173 | 3,909,070 | 3.9 M to 3.9 M (+0.08 %) |
Feb 09 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.00 | 3,000 | 45,000 | 3,905,870 | 3.9 M to 3.9 M (+0.08 %) |
Feb 09 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.00 | 1,000 | 15,000 | 3,902,870 | 3.9 M to 3.9 M (+0.03 %) |
Feb 09 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.00 | 1,000 | 15,000 | 3,901,870 | 3.9 M to 3.9 M (+0.03 %) |
Feb 04 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.63 | 73,000 | 1,141,121 | 3,900,870 | 3.8 M to 3.9 M (+1.91 %) |
Feb 04 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.63 | 21,000 | 328,268 | 3,827,870 | 3.8 M to 3.8 M (+0.55 %) |
Feb 04 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.63 | 29,611 | 462,873 | 3,806,870 | 3.8 M to 3.8 M (+0.78 %) |
Feb 04 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.80 | 7,000 | 110,600 | 3,777,259 | 3.8 M to 3.8 M (+0.19 %) |
Feb 04 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.80 | 2,000 | 31,600 | 3,770,259 | 3.8 M to 3.8 M (+0.05 %) |
Feb 04 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.80 | 3,138 | 49,580 | 3,768,259 | 3.8 M to 3.8 M (+0.08 %) |
Feb 04 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.80 | 12,000 | 189,600 | 3,765,121 | 3.8 M to 3.8 M (+0.32 %) |
Feb 04 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.80 | 4,000 | 63,200 | 3,753,121 | 3.7 M to 3.8 M (+0.11 %) |
Feb 04 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.80 | 5,000 | 79,000 | 3,749,121 | 3.7 M to 3.7 M (+0.13 %) |
Jan 29 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.72 | 60,000 | 943,140 | 3,744,121 | 3.7 M to 3.7 M (+1.63 %) |
Jan 29 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.72 | 17,000 | 267,223 | 3,684,121 | 3.7 M to 3.7 M (+0.46 %) |
Jan 29 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.72 | 25,000 | 392,975 | 3,667,121 | 3.6 M to 3.7 M (+0.69 %) |
Jan 29 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.70 | 30,000 | 471,111 | 3,642,121 | 3.6 M to 3.6 M (+0.83 %) |
Jan 29 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.70 | 9,000 | 141,333 | 3,612,121 | 3.6 M to 3.6 M (+0.25 %) |
Jan 29 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.70 | 12,600 | 197,867 | 3,603,121 | 3.6 M to 3.6 M (+0.35 %) |
Jan 29 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.66 | 69,000 | 1,080,775 | 3,590,521 | 3.5 M to 3.6 M (+1.96 %) |
Jan 29 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.66 | 20,000 | 313,268 | 3,521,521 | 3.5 M to 3.5 M (+0.57 %) |
Jan 29 2010 | FACT | ABBOTT BIOTHERAPEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 15.66 | 29,000 | 454,239 | 3,501,521 | 3.5 M to 3.5 M (+0.84 %) |
Jan 25 2010 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Payment of Exercise | F | 15.68 | 1,319 | 20,682 | 16,883 | 18.2 K to 16.9 K (-7.25 %) |
Jan 22 2010 | FACT | ABBOTT BIOTHERAPEU ... | Llana Ted | SVP Commercial & Co ... | Payment of Exercise | F | 17.39 | 2,344 | 40,762 | 42,882 | 45.2 K to 42.9 K (-5.18 %) |
Dec 22 2009 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Payment of Exercise | F | 18.03 | 202 | 3,642 | 18,202 | 18.4 K to 18.2 K (-1.10 %) |
Oct 05 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hasnain Faheem | President & CEO | Payment of Exercise | F | 17.37 | 8,937 | 155,236 | 119,930 | 128.9 K to 119.9 K (-6.94 %) |
Sep 22 2009 | FACT | ABBOTT BIOTHERAPEU ... | Llana Ted | SVP, Comm'l & Corp. ... | Grant | A | 0.00 | 15,000 | 0 | 45,226 | 30.2 K to 45.2 K (+49.63 %) |
Sep 15 2009 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP, Gen Counsel & S ... | Payment of Exercise | F | 16.34 | 1,182 | 19,314 | 25,284 | 26.5 K to 25.3 K (-4.47 %) |
Sep 09 2009 | FACT | ABBOTT BIOTHERAPEU ... | Huh Hoyoung | Director | Option Exercise | A | 15.38 | 16,667 | 256,338 | 16,667 | |
Sep 09 2009 | FACT | ABBOTT BIOTHERAPEU ... | Huh Hoyoung | Director | Grant | A | 0.00 | 8,333 | 0 | 8,333 | 0 to 8.3 K |
Sep 15 2009 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Payment of Exercise | F | 16.34 | 1,379 | 22,533 | 18,404 | 19.8 K to 18.4 K (-6.97 %) |
Sep 08 2009 | FACT | ABBOTT BIOTHERAPEU ... | BAUPOST GROUP LLC/MA | 10% Owner | Sell | S | 15.43 | 579,432 | 8,942,953 | 3,506,875 | 4.1 M to 3.5 M (-14.18 %) |
Sep 08 2009 | FACT | ABBOTT BIOTHERAPEU ... | BAUPOST GROUP LLC/MA | 10% Owner | Sell | S | 15.49 | 27,900 | 432,283 | 4,086,307 | 4.1 M to 4.1 M (-0.68 %) |
Sep 08 2009 | FACT | ABBOTT BIOTHERAPEU ... | BAUPOST GROUP LLC/MA | 10% Owner | Sell | S | 15.50 | 10,200 | 158,100 | 4,114,207 | 4.1 M to 4.1 M (-0.25 %) |
Sep 08 2009 | FACT | ABBOTT BIOTHERAPEU ... | BAUPOST GROUP LLC/MA | 10% Owner | Sell | S | 15.40 | 100,000 | 1,540,000 | 4,124,407 | 4.2 M to 4.1 M (-2.37 %) |
Sep 08 2009 | FACT | ABBOTT BIOTHERAPEU ... | BAUPOST GROUP LLC/MA | 10% Owner | Sell | S | 15.39 | 150,000 | 2,308,950 | 4,224,407 | 4.4 M to 4.2 M (-3.43 %) |
Aug 20 2009 | FACT | ABBOTT BIOTHERAPEU ... | Rolfe Mark | Sr. Vice Pres. and ... | Option Exercise | A | 10.86 | 64,000 | 695,040 | 64,000 | |
Aug 20 2009 | FACT | ABBOTT BIOTHERAPEU ... | Rolfe Mark | Sr. Vice Pres. and ... | Grant | A | 0.00 | 21,333 | 0 | 21,333 | 0 to 21.3 K |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Option Exercise | A | 9.95 | 45,760 | 455,312 | 45,760 | |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Grant | A | 0.00 | 15,251 | 0 | 45,989 | 30.7 K to 46 K (+49.62 %) |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP, Prod. Ops. & Qu ... | Option Exercise | A | 9.95 | 16,000 | 159,200 | 16,000 | |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP, Prod. Ops. & Qu ... | Grant | A | 0.00 | 5,325 | 0 | 18,919 | 13.6 K to 18.9 K (+39.17 %) |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | Llana Ted | SVP, Comm'l & Corp. ... | Option Exercise | A | 9.95 | 26,693 | 265,595 | 26,693 | |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | Llana Ted | SVP, Comm'l & Corp. ... | Grant | A | 0.00 | 8,896 | 0 | 30,226 | 21.3 K to 30.2 K (+41.71 %) |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP, Gen Counsel & S ... | Option Exercise | A | 9.95 | 20,800 | 206,960 | 20,800 | |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP, Gen Counsel & S ... | Grant | A | 0.00 | 6,923 | 0 | 25,266 | 18.3 K to 25.3 K (+37.74 %) |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Option Exercise | A | 9.95 | 7,000 | 69,650 | 7,000 | |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Grant | A | 0.00 | 4,500 | 0 | 19,783 | 15.3 K to 19.8 K (+29.44 %) |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hasnain Faheem | President & CEO | Option Exercise | A | 9.95 | 83,000 | 825,850 | 83,000 | |
Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hasnain Faheem | President & CEO | Grant | A | 0.00 | 27,667 | 0 | 127,667 | 100 K to 127.7 K (+27.67 %) |
Jul 28 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP Product Operatio ... | Payment of Exercise | F | 8.28 | 492 | 4,074 | 13,595 | 14.1 K to 13.6 K (-3.49 %) |
May 28 2009 | FACT | ABBOTT BIOTHERAPEU ... | Goodwin Bradford S | Director | Option Exercise | A | 9.56 | 6,667 | 63,737 | 6,667 | |
May 28 2009 | FACT | ABBOTT BIOTHERAPEU ... | Goodwin Bradford S | Director | Grant | A | 0.00 | 3,334 | 0 | 13,334 | 10 K to 13.3 K (+33.34 %) |
May 28 2009 | FACT | ABBOTT BIOTHERAPEU ... | EMSTER KURT VON | Director | Option Exercise | A | 9.56 | 3,334 | 31,873 | 3,334 | |
May 28 2009 | FACT | ABBOTT BIOTHERAPEU ... | EMSTER KURT VON | Director | Grant | A | 0.00 | 1,667 | 0 | 10,000 | 8.3 K to 10 K (+20.00 %) |
May 28 2009 | FACT | ABBOTT BIOTHERAPEU ... | LYONS GARY A | Director | Option Exercise | A | 9.56 | 5,000 | 47,800 | 5,000 | |
May 28 2009 | FACT | ABBOTT BIOTHERAPEU ... | LYONS GARY A | Director | Grant | A | 0.00 | 2,500 | 0 | 10,833 | 8.3 K to 10.8 K (+30.00 %) |
May 28 2009 | FACT | ABBOTT BIOTHERAPEU ... | Parkinson David Ross | Director | Option Exercise | A | 9.56 | 5,000 | 47,800 | 5,000 | |
May 28 2009 | FACT | ABBOTT BIOTHERAPEU ... | Parkinson David Ross | Director | Grant | A | 0.00 | 2,500 | 0 | 10,833 | 8.3 K to 10.8 K (+30.00 %) |
Apr 06 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Option Exercise | A | 9.55 | 20,980 | 200,359 | 20,980 | |
Apr 06 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Sell | D | 9.79 | 1,478 | 14,470 | 30,738 | 32.2 K to 30.7 K (-4.59 %) |
Apr 06 2009 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Option Exercise | A | 9.55 | 6,866 | 65,570 | 6,866 | |
Apr 06 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP Product Operatio ... | Option Exercise | A | 9.55 | 16,856 | 160,975 | 16,856 | |
Apr 06 2009 | FACT | ABBOTT BIOTHERAPEU ... | McCamish Mark Anthony | Sr. VP & Chief Medi ... | Option Exercise | A | 9.55 | 19,045 | 181,880 | 19,045 | |
Apr 06 2009 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP General Counsel ... | Option Exercise | A | 9.55 | 6,422 | 61,330 | 6,422 | |
Feb 23 2009 | FACT | ABBOTT BIOTHERAPEU ... | McCamish Mark Anthony | Sr. VP & Chief Medi ... | Payment of Exercise | F | 6.56 | 1,780 | 11,677 | 13,200 | 15 K to 13.2 K (-11.88 %) |
Feb 24 2009 | FACT | ABBOTT BIOTHERAPEU ... | EMSTER KURT VON | Director | Option Exercise | A | 6.50 | 16,667 | 108,336 | 16,667 | |
Feb 24 2009 | FACT | ABBOTT BIOTHERAPEU ... | EMSTER KURT VON | Director | Grant | A | 0.00 | 8,333 | 0 | 8,333 | 0 to 8.3 K |
Feb 02 2009 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP, Gen Counsel & S ... | Payment of Exercise | F | 6.08 | 474 | 2,882 | 18,343 | 18.8 K to 18.3 K (-2.52 %) |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | McCamish Mark Anthony | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 12,405 | 0 | 14,980 | 2.6 K to 15 K (+481.75 %) |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Option Exercise | A | 6.17 | 14,000 | 86,380 | 14,000 | |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Payment of Exercise | F | 6.17 | 237 | 1,462 | 15,283 | 15.5 K to 15.3 K (-1.53 %) |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Grant | A | 0.00 | 9,000 | 0 | 15,520 | 6.5 K to 15.5 K (+138.04 %) |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Grant | A | 0.00 | 1,653 | 0 | 6,520 | 4.9 K to 6.5 K (+33.96 %) |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Grant | A | 0.00 | 3,860 | 0 | 4,867 | 1 K to 4.9 K (+383.32 %) |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | CROSS HERB | Corp Controller/Pri ... | Grant | A | 0.00 | 551 | 0 | 1,007 | 456 to 1 K (+120.83 %) |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP, Product and Qua ... | Option Exercise | A | 6.17 | 32,000 | 197,440 | 32,000 | |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP, Product and Qua ... | Grant | A | 0.00 | 10,650 | 0 | 14,087 | 3.4 K to 14.1 K (+309.86 %) |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hora Maninder | VP, Product and Qua ... | Grant | A | 0.00 | 2,756 | 0 | 3,437 | 681 to 3.4 K (+404.70 %) |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | Llana Ted | SVP, Commercial and ... | Option Exercise | A | 6.17 | 64,000 | 394,880 | 64,000 | |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | Llana Ted | SVP, Commercial and ... | Grant | A | 0.00 | 21,330 | 0 | 21,330 | 0 to 21.3 K |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hasnain Faheem | President & CEO | Option Exercise | A | 6.17 | 300,000 | 1,851,000 | 300,000 | |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | Hasnain Faheem | President & CEO | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Option Exercise | A | 6.17 | 64,000 | 394,880 | 64,000 | |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Grant | A | 0.00 | 21,330 | 0 | 32,216 | 10.9 K to 32.2 K (+195.94 %) |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Grant | A | 0.00 | 8,270 | 0 | 10,886 | 2.6 K to 10.9 K (+316.13 %) |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | LYONS GARY A | Director | Option Exercise | A | 6.17 | 16,667 | 102,835 | 16,667 | |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | LYONS GARY A | Director | Grant | A | 0.00 | 8,333 | 0 | 8,333 | 0 to 8.3 K |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | Parkinson David Ross | Director | Option Exercise | A | 6.17 | 16,667 | 102,835 | 16,667 | |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | Parkinson David Ross | Director | Grant | A | 0.00 | 8,333 | 0 | 8,333 | 0 to 8.3 K |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP, Gen Counsel & S ... | Option Exercise | A | 6.17 | 32,000 | 197,440 | 32,000 | |
Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | Sarena Francis Willard | VP, Gen Counsel & S ... | Grant | A | 0.00 | 10,650 | 0 | 18,817 | 8.2 K to 18.8 K (+130.40 %) |